these results indicate that propranolol administration may cause a potentiation of norepinephrine activity specifically at alpha receptors , due to concurrent beta receptor blockade and inhibition of norepinephrine reuptake and a decrease in dopamine activity at dopaminergic receptor sites due to an inhibition of dopamine formation .
C0282151
dopaminergic
C0013030
dopamine